Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

HPV is the most common sexually transmitted biological agent and is the cause of many
conditions in men and women, including precancer lesions and cancer. Three prophylactic …

Objectives Sexual gender minority (SGM) populations are at risk for human papillomavirus
(HPV)–related cancers of the anogenital tract and oropharynx and often face barriers to …

Background The aim of this study was to assess the cost-effectiveness of human
papillomavirus (HPV) vaccination in addition to the current cervical cancer screening …

Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …

Abstract “Cross-reactivity”(the observed immune response against pathogen types not
specifically targeted by the vaccine antigen composition) and “cross-protection”(clinical …

Context.—Histologic distinction between condyloma acuminatum and various benign and
malignant condyloma-like lesions in the anogenital area poses a common diagnostic …